Problem: Missing data due to withdrawals
• Important principles for conducting an unbiased study -Randomization -Intent-to-treat (ITT) analysis
• Missing data due to withdrawal from study -Undermine the comparability of randomized groups -Potential bias for treatment comparison -In many situations, MAR appears to be reasonable; but the possibility of MNAR can never be ruled
• Follow-up of patients after discontinuation from study mediation -Support ITT analysis -Complicate interpretation: receive effective rescue therapies
Methods of handling missing data in time-toevent analysis
• Prematurely discontinue follow-up for the assigned treatment prior to event or the end of study
• Censor patients at the time of discontinuation • Conduct sensitivity analyses based on different assumptions to evaluate the potential impact of missing outcomes on the trial conclusion
• The primary MAR assumption serves as an anchor point for the sensitivity analysis to assess the robustness of the treatment effect inferences
• Supplement the primary analysis with a number of modifications, relating treatment effect inferences to one or more parameters that capture departures from the MAR.
• The degree to which conclusions are stable across such analyses provides an indication of the confidence that can be placed in them
• Modifications to a basic model -Untestable assumptions regarding the missing response distribution (pattern-mixture model) -How the probability of missingness related to the unobserved outcomes (selection model)
Proposed sensitivity analysis method
• Multiple imputation (MI): impute experiences for discontinued patients during their unobserved remaining times as if they continued to be followed until the end of study, based on the conditional survival distribution.
• Sensitivity parameter (θ): fixed hazard ratio for a withdrawer having an event after the corresponding censor time relative to the patients still remaining on their treatment, allowing for different postdiscontinuation experience. (Pattern-mixture model).
• Sensitivity assessment:
-Anchors on the primary MAR assumption ( θ= 1) -investigates the impact of departures from MAR assumption by summarizing the treatment effect inference as a function of θ over a plausible range. 
Kaplan-Meier multiple imputation (KMMI) procedure
• A single treatment group of n patients with the same planned follow-up time t*
• M distinct failure times (t 1 < t 2 <·····< t M )
• The Kaplan-Meier estimates have support on the observed failure times ( , , ⋯ , )
• K distinct discontinuation times (c 1 < c 2 <·····< c K ) before t*
• With k indexing the censoring times before t*, , denotes the jth failure time after c k , , denotes the latest failure time prior to c k if c k  t 1 and t k;0 =0 if c k < t 1 . 
Construct the estimated conditional failure time distribution given a fixed hazard ratio (sensitivity parameter)
• Sensitivity parameter: the hazard ratio for a discontinued patient having an event after c k relative to the patients still remaining on their treatment.
• Under the proportional hazard assumption, the survival function for a discontinued 
Summary
• Does not attempt to get more accurate estimation for treatment effects, but to understand robustness of the treatment effect inference.
• Address the question for what the long-term benefit of initial assignment would be if patients with premature discontinuation were followed to the end of the study without other treatment.
• If it is unlikely to reach the values that would alter the study conclusion, then the results of the primary analysis is considered to be robust from a clinical perspective.
• When the inference about treatment effects could be overturned for plausible values of sensitivity parame, the primary analysis results should be viewed as equivocal, therefore should be interpreted with more caution.
• KMMI method: evaluate the implication of missing outcomes and the non-proportional hazards related to withdrawal simultaneously.
• PHMI method: the missing data issue is addressed separately in its own right
• Anchors on the primary MAR assumption, directly exploring the effect of departures from the non-informative censoring assumption made in the primary analysis.
• Calibration toward the worst comparison analysis through how it penalizes premature discontinuation for the test treatment.
• The interpretation of the sensitivity parameter is transparent in the sense that the parameter is based on a standard measurement for analyzing time-to-event data, and consequently may be more understandable to non-statisticians.
Thank You Very Much

